← Leaderboards
Cindy S Chu
University Of Oxford
$3,588,034
Attributed
$3,588,034
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,588,034 · 1
By mechanism
U01$3,588,034 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Drug Interactions”
- Suma Babu · Massachusetts General Hospital$15,344,018
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Michael George Natchus · Emory University$10,548,554
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
Research focus
Drug InteractionsAccelerationAcuteAminoquinolinesAnemiaAdultAftercareArtemetherAsiaBenflumetolBibliographyBloodChildChloroquineClinical TrialsCountryCyp2d6 GeneDensityDesignDetection MethodDevelopmental Delay DisordersDoseDouble-Blind MethodEnrollment
Grant awards (4)
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia$1,357,354
U01 · FY2025 · AI · contact PI
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia$117,395
U01 · FY2025 · AI · contact PI
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia$1,045,386
U01 · FY2024 · AI · contact PI
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia$1,067,899
U01 · FY2023 · AI · contact PI